It is estimated that the Medicaid program overall could save as much as $5.5 billion annually on by switching to perphenazine.
In addition, lawsuits are popping up all over the country filed on behalf of state Medicaid programs charging the drug makers with promoting the off-label use of the atypicals and seeking payment for medical costs billed to Medicaid arising from side effects of the drugs.
For more information for injured parties go to lawyers and settlements.com
Evelyn Pringle
Next Page 1 | 2 | 3 | 4 | 5 | 6
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
